Correspondence to Professor Stian Lydersen, Regional Centre for Child and Youth Mental Health and Child Welfare, Norwegian University of Science and Technology, Trondheim, Trøndelag, Norway; ...
Objective Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with unknown aetiology. Epstein-Barr virus (EBV) is an environmental factor associated with SLE. EBV maintains latency in ...
Background: Magnetic resonance imaging (MRI) is increasingly used to detect inflammation in the spine of patients with ankylosing spondylitis (AS). Objectives: To detect differentially the presence ...
Correspondence to Professor Maarten Boers, Epidemiology & Biostatistics, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam 1007 MB, Netherlands; eb{at}vumc.nl Objectives Mortality in ...
Psoriasis is a common chronic, recurrent, immune mediated disease of the skin and joints. It can have a significant negative impact on the physical, emotional, and, psychosocial wellbeing of affected ...
Novel machine learning methods open the door to advances in rheumatology through application to complex, high-dimensional data, otherwise difficult to analyse. Results from such efforts could provide ...
Objective The aim of this study was to assess the predictive value of tenderness in the absence of swelling with consideration of other potential risk factors for subsequent radiographic progression ...
Correspondence to Dr Yukinori Okada, Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita 565-0871, Japan; yokada{at}sg.med.osaka-u.ac.jp Objective Alteration of the ...
Objectives (1) To develop risk prediction models for knee osteoarthritis (OA) and (2) to estimate the risk reduction that results from modification of potential risk factors. Method This was a 12-year ...
Rheumatoid arthritis (RA) is characterised by chronic synovial inflammation of multiple large and small joints in the upper and lower limbs.1 The pathogenesis of RA is complex and involves the ...
Background JAK inhibitors (JAKi) are a new class of drugs developed for the treatment of different immune-mediated inflammatory diseases (IMIDs). Thrombotic events have been reported in some long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results